Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04851301Phase 2Active, not recruiting
Phase 2, randomised, double-blind trial in temporomandibular disorder (TMD) (3 arms), sponsored by University of Maryland, Baltimore. Primary endpoint: Ischemic pain endurance. Started Nov 2021; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04851301.